A risk model to predict chemotherapy dose attenuation in patients with breast cancer.
Publication
, Conference
Agboola, O; Crawford, J; Dale, D; Lyman, GH
Published in: BREAST CANCER RESEARCH AND TREATMENT
2003
Duke Scholars
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
2003
Volume
82
Start / End Page
S155 / S155
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Agboola, O., Crawford, J., Dale, D., & Lyman, G. H. (2003). A risk model to predict chemotherapy dose attenuation in patients with breast cancer. In BREAST CANCER RESEARCH AND TREATMENT (Vol. 82, pp. S155–S155).
Agboola, O., J. Crawford, D. Dale, and G. H. Lyman. “A risk model to predict chemotherapy dose attenuation in patients with breast cancer.” In BREAST CANCER RESEARCH AND TREATMENT, 82:S155–S155, 2003.
Agboola O, Crawford J, Dale D, Lyman GH. A risk model to predict chemotherapy dose attenuation in patients with breast cancer. In: BREAST CANCER RESEARCH AND TREATMENT. 2003. p. S155–S155.
Agboola, O., et al. “A risk model to predict chemotherapy dose attenuation in patients with breast cancer.” BREAST CANCER RESEARCH AND TREATMENT, vol. 82, 2003, pp. S155–S155.
Agboola O, Crawford J, Dale D, Lyman GH. A risk model to predict chemotherapy dose attenuation in patients with breast cancer. BREAST CANCER RESEARCH AND TREATMENT. 2003. p. S155–S155.
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
2003
Volume
82
Start / End Page
S155 / S155
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences